Status:

COMPLETED

Fundamental and Clinical Study of Cochlear Synaptopathy

Lead Sponsor:

CHU de Reims

Conditions:

Hearing Loss

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

In humans, surface electrophysiological recording of the cochlear nerve in response to a sound stimulus provides information about the integrity and function of synapses (synaptic transmission) and ne...

Detailed Description

During functional surgery on the cerebellopontine angle, a ball electrode is placed on the human cochlear nerve to monitor hearing. Once the electrode is in place, clicks and random noise bands will b...

Eligibility Criteria

Inclusion

  • inclusion criteria :
  • Patients with normal hearing will be included:
  • male or female
  • over 18 and up to 70 years of age
  • normal otoscopic examination
  • due to undergo surgery on the cerebellopontine angle (microvascular decompression).
  • free of neuro-sensory deafness, defined by mean hearing thresholds of less than or equal to 20 dB HL in pure tone audiometry in air conduction bilaterally on the side of the ear operated on and on the non-operated side from 0.25 to 8 kHz
  • affiliated to a social security scheme
  • have read the information note describing the study and have agreed in writing to take part by signing the informed consent form.
  • Patients with a hearing impairment will be included:
  • male or female
  • over 18 and up to 70 years of age
  • normal otoscopic examination
  • due to undergo surgery on the cerebellopontine angle (microvascular decompression).
  • have a sensorineural hearing loss defined by hearing thresholds of 20 dB HL or better from 0.25 to 2 kHz and from 20 dB HL excluded to 55 dB HL at frequencies above 2 kHz.
  • have read the information note describing the study and have agreed in writing to take part by signing the informed consent form.
  • exclusion criteria :
  • \- Patients will be excluded from the study for whom the auditory nerve is not accessible during surgery, in particular because of complete tumour invasion of the cochlear nerve (stage III and IV neuroma, advanced meningioma) or because of a particular anatomical feature not identified during the preoperative examination, making it impossible to expose the nerve for recordings (protrusion of the posterior surface of the rock).

Exclusion

    Key Trial Info

    Start Date :

    March 21 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 4 2025

    Estimated Enrollment :

    19 Patients enrolled

    Trial Details

    Trial ID

    NCT06556160

    Start Date

    March 21 2023

    End Date

    November 4 2025

    Last Update

    December 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Damien JOLLY

    Reims, France